SYSTEMIC LUPUS ERYTHEMATOSIS (SLE) WITH KIDNEY DISEASE Dr. Naomi Rothfield is the Principal Investigator at our site for this study. This study is sponsored by La Jolla Pharmaceutical Company. The kidney disease must have been active within the past four years but be controlled and stable at study entrance. There are weekly visits with a small (2ml) intravenous injection of study drug or placebo.
For further information, please contact Dr. Naomi Rothfield by email: Rothfield@nso.uchc.edu
SCLERODERMA - The National Institutes of Health (NIH) is conducting a study to determine if oral collagen is effective in patients with scleroderma. We are one of ten centers across the United States participating in this project. If your scleroderma has been diagnosed within the last ten years and involves your chest, abdomen, arms or legs, you may be eligible.
If you are interested in this study, please call:
Naomi Rothfield, MD 860-679-3604
Frances Ingenito, NP 860-679-2589
FINISHED TRIALS:
TREATMENT OF SEVERE RAYNAUD'S
Oral Iloprost - The efficacy of oral Iloprost (Berlex Laboratories) in Raynaud's was evaluated in a multicenter study -- including Dr. Rothfield's patients. The results indicated that Raynaud's duration and the number of ulcers did not differ significantly in patients taking Iloprost when compared to those who received the placebo. This study was published in the American College of Rheumatology's journal: Arthritis Rheum 41:670;1998.
________________________________________________________________Division of Rheumatic Diseases
Basic Science Page
Clinical Research Page
Patient Care Page
Calendar of Scientific Activities and Events
Back to Home Page: Division of Rheumatic Diseases
__________________________________________
This site was created by Dolores Vázquez-Abad, MD, and is maintained by Naomi F. Rothfield, MD, © Copyright 1997. All rights reserved. If you experience any broken links or other difficulties with this site, please email us.